Compare RXRX & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXRX | MQ |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2021 | 2021 |
| Metric | RXRX | MQ |
|---|---|---|
| Price | $4.21 | $4.65 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | ★ $8.00 | $5.43 |
| AVG Volume (30 Days) | ★ 23.2M | 3.6M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $43,689,000.00 | ★ $588,561,000.00 |
| Revenue This Year | $6.74 | $25.93 |
| Revenue Next Year | $34.31 | $18.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 20.11 |
| 52 Week Low | $3.79 | $3.48 |
| 52 Week High | $12.36 | $7.04 |
| Indicator | RXRX | MQ |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 38.24 |
| Support Level | $4.05 | $4.80 |
| Resistance Level | $4.43 | $5.14 |
| Average True Range (ATR) | 0.23 | 0.12 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 15.60 | 3.64 |
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.